A hypoxia-responsive supramolecular formulation for imaging-guided photothermal therapy

Tian-Xing Zhang,Xiaoxue Hou,Yong Kong,Fan Yang,Yu-Xin Yue,Muhammad Raza Shah,Hua-Bin Li,Fan Huang,Jianfeng Liu,Dong-Sheng Guo
DOI: https://doi.org/10.7150/thno.67036
IF: 11.6
2022-01-01
Theranostics
Abstract:Photothermal agents (PTAs) based on organic small-molecule dyes emerge as promising theranostic strategy in imaging and photothermal therapy (PTT). However, hydrophobicity, photodegradation, and low signal-to-noise ratio impede their transformation from bench to bedside. In this study, a novel supramolecular PTT formulation by a stimuli-responsive macrocyclic host is prepared to overcome these obstacles of organic small-molecule PTAs. <b>Methods:</b> Sulfonated azocalix[4]arene (SAC4A) was synthesized as a hypoxia-responsive macrocyclic host. Taking IR780 as an example, the supramolecular nanoformulation IR780@SAC4A was constructed by grinding method, and its solubility, photostability, and photothermal conversion were evaluated. The hypoxia tumor-selective imaging and supramolecular PTT of IR780@SAC4A were further evaluated <i>in vitro</i> and <i>in vivo</i>. <b>Results:</b> IR780@SAC4A is capable of enhancing the solubility, photostability, and photothermal conversion of IR780 significantly, which achieve this supramolecular formulation with good imaging-guided PTT efficacy <i>in vitro</i> and <i>in vivo</i>. <b>Conclusions:</b> This study demonstrates that the supramolecular PTT strategy is a promising cancer theranostic method. Moreover, this supramolecular approach is applicative to construct kinds of supramolecular PTAs, opening a general avenue for extending smart PTT formulations.
medicine, research & experimental
What problem does this paper attempt to address?